Comment on Fust et al. The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan. Vaccines 2024, 12, 434
We noted three key inconsistencies in the Moderna-funded cost-effectiveness analysis by Fust et al [...].
Authors
- Hannah R. Volkman (ORCID: https://orcid.org/0000-0001-7274-9641)
- Mustapha M. Mustapha (ORCID: https://orcid.org/0000-0002-4102-2965)
- Jennifer L. Nguyen (ORCID: https://orcid.org/0000-0002-4064-0227)
- Luis Jódar (ORCID: https://orcid.org/0000-0003-1246-530X)
- John M. McLaughlin
Institutions
- Pfizer (United States) (US)
Publication Details
- Journal
- Vaccines
- Published
- 2024-10-17
- DOI
- https://doi.org/10.3390/vaccines12101174
- Citations
- 1
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- Pfizer